Free accessResearch articleFirst published online 2001-06
Greater Expression of Transforming Growth Factor α and Proliferating Cell Nuclear Antigen Staining in Mouse Hepatoblastomas Than Hepatocellular Carcinomas Induced by a Diethylnitrosamine-Sodium Phenobarbital Regimen
Transforming growth factor α (TGF-α) is a potent stimulator of normal hepatocyte proliferation, considered to have relationship to the liver regeneration or carcinogenesis. In this study, we investigated immunohistochemically the association between expression of TGF-α and cell proliferation activity in mouse hepatoblastoma s (HBs) and hepatocellular carcinomas (HCCs) induced in B6C3F1 mice by diethylnitrosamine and sodium phenobarbital. The TGF-α-positive rate in HBs (29.2%) was significantly higher than that in HCCs (12.7%). Likewise, the proliferating cell nuclear antigen-positive rate (22.2%) was higher than the HCC value (14.5%). On the individual data for both TGF-α and PCNA, most of the HBs showed higher positive rates than HCCs. In HBs, TGF-α was localized only in the nuclei, whereas some HCC cells stained positive both in their nuclei and cytoplasm (0.6%). These results suggest expression of TGF-α and its localization might be linked to cell proliferation and play a role in malignant progression of mouse HBs.
Brown PI, Lam R., Lakshmanan J., Fisher DA (1990). Transforming growth factor alpha in developing rats. Am J Physiol259: E256—260.
2.
Calvert RJ, Tashiro Y., Buzard GS, Diwan BA, Weghorst CM (1995). Lack of p53 point mutations in chemically induced mouse hepatoblastomas: An end-stage, highly malignant hepatocellular tumor . Cancer Lett95: 175—180.
3.
Derynck R. (1988). Transforming growth factor α. Cell54: 593—595.
4.
Derynck R., Goeddel DV, Ullrich A., Gutterman JU, Williams RD, Bringman TS, Berger WH (1987). Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res47: 707—712.
5.
Diwan BA, Henneman JR, Rice JM ( 1995). Further evidence for promoter-dependent development of hepatoblastoma in the mouse. Cancer Lett89: 29—35.
6.
Diwan BA, Ward JM, Rice JM ( 1989). Promotion of malignant `embryonal' liver tumors by phenobarbital: Increased incidence and shortened latency of hepatoblastomas in (DBA/2 x C57BL/6) F1 mice initiated with N-nitrosodiethylamine. Carcinogenesis10: 1345—1348.
7.
Diwan BA, Ward JM, Rice JM ( 1992). Origin and pathology of hepatoblastoma in mice. In: The Role of Cell Types in Hepatocarcinogenesi s, Sirica AE (ed). CRC Press, Boca Raton, FL, pp 71—78.
8.
Harada T., Enomoto A., Boorman GA, Maronpot RR (1999). Liver and gall-bladder. In: Pathology of the Mouse, Maronpot RR (ed). Cache River Press, Vienna, IL, pp 119—183.
9.
Hsia CC, Axiotis CA, Di Bisceglie AM, Tabor E. (1992). Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver . Cancer70: 1049—1056.
10.
Imai T., Tashiro T., Hayakawa K., Nakanowatari J., Fukuta T., Hosokawa S., Tsukamoto T., Inada K., Tatematsu M. (1998). Stable expression of glutathione S-transferase P-form mRNA and TGF-α immunohistochemical expression are useful markers for identification of persistent nodules from an early stage in rat hepatocarcinogenesis . J Toxicol Pathol11: 249—255.
11.
Imamura T., Oka S., Tanahashi T., Okita Y. (1994). Cell cycle-dependent nuclear localization of exogenously added fibroblast growth factor-1 in BALB/c 3T3 and human vascular endothelial cells. Exp Cell Res215: 363— 372.
12.
Jhappan C., Stahle C., Harkins RN, Fausto N., Smith GH, Merlino GT (1990). TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas . Cell61: 1137— 1146.
13.
Kaufmann WK , Byrd LL, Palmieri D., Nims RW, Rice JM (1997). TGF-α sustains clonal expansion by promoter-dependent, chemically initiated rat hepatocytes. Carcinogenesis18: 1381—1387.
14.
Kira S., Nakanishi T., Suemori S., Kitamoto M., Watanabe Y., Kajiyama G. (1997). Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma. Liver17: 177— 182.
15.
Kiss A., Szepesi A., Lotz G., Nagy P., Schaff Z. (1998). Expression of transforming growth factor-α in hepatoblastoma. Cancer83: 690—697.
16.
Kobayashi K. , Kusakabe M., Okada M., Sakairi T., Goto K., Tsuchiya T., Sugimoto J., Sano F., Mutai M. (2000). Immunohistochemical localization of transforming growth factor alpha in chemically induced rat hepatocellular carcinomas with reference to differentiation and proliferation. Toxicol Pathol28: 664—667.
17.
Kojima T., Mutai M., Sawada N., Zhong Y., Oyamada M., Mori M. ( 1993). Histopathological studies of mouse hepatoblastoma induced by DEN. J Toxicol Pathol6 (Suppl): 21—28.
18.
Lee GH, Merlino G., Fausto N. (1992). Development of liver tumors in transforming growth factor α transgenic mice. Cancer Res52: 5162—5170.
19.
LiuC., Tsao MS, Grisham JW (1988). Transforming growthfactors produced by normal and neoplastically transformed rat liver epithelial cells in culture. Cancer Res48: 850—855.
20.
Luetteke NC , Michalopoulos GK, Teixidó J., Gilmore R., Massagué J., Lee DC (1988). Characterization of high molecular weight transforming growth factor α produced by rat hepatocellular carcinoma cells. Biochemistry27: 6487—6494.
21.
Marti U., Burwen SJ, Jones AL (1989). Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: An update. Hepatology9: 126—138.
22.
Mead JE, Fausto N. (1989). Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA86: 1558—1562.
23.
Morimitsu Y. , Hsia CC, Kojiro M., Tabor E. (1995). Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: Relative expression of transforming growth factor-α and its receptor in the different areas of tumor. Hum Pathol26: 1126—1132.
24.
Nonoyama T. , Fullerton F., Reznik G., Bucci TJ, Ward JM (1988). Mouse hepatoblastomas: A histologic, ultrastructural, and immunohistochemical study. Vet Pathol25: 286—296.
25.
Sandgren EP , Luetteke NC, Palmiter RD, Brinster RL, Lee DC (1990). Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell61: 1121—1135.
26.
Sandgren EP , Luetteke NC, Qiu TH, Palmiter RD, Brinster RL, Lee DC (1993). Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol13: 320—330.
27.
Savion N., Vlodavsky I., Gospodarowicz D. (1981). Nuclear accumulation of epidermal growth factor in cultured bovine corneal endothelial and granulosa cells. J Biol Chem256: 1149—1154.
28.
Steinmetz KL , Klaunig JE (1996). Transforming growth factor-α in carcinogen-induced F344 rat hepatic foci. Toxicol Appl Pharmacol140: 131—145.
29.
Tanno S., Ogawa K. (1994). Abundant TGFαprecursor and EGF receptor expression as a possible mechanis m for the preferential growth of carcinogen-induced preneoplastic and neoplastic hepatocytes in rats. Carcinogenesis15:1689—1694.
30.
Turusov VS, Deringer MK, Dunn TB, Stewart HL (1973). Malignantmouseliver tumors resembling human hepatoblastomas . J Natl Cancer Inst51: 1689—1695.
31.
Yankner BA, Shooter EM (1979). Nerve growth factor in the nucleus: Interaction with receptors on the nuclear membrane. Proc Natl Acad Sci USA76: 1269—1273.
